Here is some elaborating information about the US tests.
Independent Testing In The US Demonstrates Response Biomedical's RAMP(TM) Anthrax Test Exceeds Previously Announced Performance
TSX Venture Exchange: RBM
VANCOUVER, July 26 /CNW/ - Response Biomedical Corp. (RBM: TSX Venture Exchange), today released the results of initial testing conducted by Intertox, Inc. - an independent, Seattle-based public and occupational health firm, showing the Company's RAMP(TM) Anthrax Test has achieved a reliable detection level of less than 1,600 spores with Bacillus anthracis and no false positive readings.
The testing was performed under the direction of Intertox toxicologist Dr. Richard C. Pleus using live viable Anthrax Spore Vaccine and B. thuringiensis. Details of the test protocol and results will be available on Response Biomedical's website early next month.
Although the RAMP Anthrax Test has not been evaluated for sensitivity by the U.S. Centers for Disease Control and Prevention (CDC), mounting independent and internal scientific analysis demonstrate RAMP is not subject to the performance limitations of competing technologies and can detect anthrax spores in quantities well below an infectious dose, without producing false positive readings. The 10,000 spore level is used by the CDC to define a potentially infectious dose. No other competitive technology purports to have remotely comparable performance characteristics.
"While not surprising, these results are significant because they serve as yet another credible independent validation of the strength of our technology and address skepticism in the marketplace," says Bill Radvak, President and CEO. "In the absence of industry regulation, we are committed to prove our competitive advantages and differentiate ourselves in the market through independent scientific evidence. Men and women on the front lines of bioterrorism deserve the very best technology, and we're determined to make sure they know where to get it."
On May 29, 2002, Response Biomedical announced the commercial launch of the RAMP Anthrax Test - the world's most reliable rapid on-site detection system available for identifying a hoax or a potentially infectious dose of anthrax. The battery operated RAMP Reader weighs less than five pounds and is easy to operate with single-use disposable cartridges. Data can be stored on the device and uploaded to a printer or computer. The system is available for an all-inclusive price of less than US$10,000. |
